Regulus Therapeutics said this week that it has begun collaborating with researchers at the University of California, San Diego, on microRNA-based treatments for angiogenic diseases.

The research will combine Regulus' miRNA platform with UCSD's expertise in animal models of angiogenesis, the company said.

According to Regulus, the effort will be funded by the UC Discovery Grant program, which supports collaborative research between the university and industry. Financial terms of the grant were not disclosed.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In Science this week: mtDNA analysis give glimpse into decline of Neanderthals in Europe, and more.

The University of Arizona's Raina Maier writes that an understanding of the Earth's microbiome is needed.

The proposed Canadian budget emphasizes partnerships with industry, Nature News reports.

An Australian study of personalized medicine has run into problems as it recruits patients.